0001209191-15-078180.txt : 20151103
0001209191-15-078180.hdr.sgml : 20151103
20151103180457
ACCESSION NUMBER: 0001209191-15-078180
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151030
FILED AS OF DATE: 20151103
DATE AS OF CHANGE: 20151103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sachdev Amit
CENTRAL INDEX KEY: 0001406338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 151194898
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-10-30
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001406338
Sachdev Amit
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Policy, Access & Value
Common Stock
2015-10-30
4
S
0
700
123.34
D
84201
D
Common Stock
2015-10-30
4
S
0
1500
124.94
D
82701
D
Common Stock
2015-10-30
4
S
0
2638
126.01
D
80063
D
Common Stock
2015-10-30
4
S
0
1100
126.61
D
78963
D
Common Stock
882
I
401(k)
Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $123.34 (range $123.06 to $123.66).
Open market sales reported on this line occurred at a weighted average price of $124.94 (range $124.40 to $125.37).
Open market sales reported on this line occurred at a weighted average price of $126.01 (range $125.43 to $126.39).
Open market sales reported on this line occurred at a weighted average price of $126.61 (range $126.44 to $126.75).
Omar White, Attorney-In-Fact
2015-11-03